drugset / Trial / NCT02870361

Influence of Central Nervous Insulin Sensitivity on Insulin Secretion

NCT02870361

Completed 15 enrolled University Hospital Tuebingen
RandomizedCrossoverDouble-blindBasic science

Summary

Insulin resistance is a central pathophysiological component of type 2 diabetes and is associated with a high risk of cardiovascular disease. The tissue in which it manifests are mainly muscle, liver, and adipose tissue. Since the transport of glucose to the brain is independent of insulin, this organ has traditionally not been studied in this regard. In animal experiments, however, knockout of the insulin receptor in the brain leads to obesity and peripheral insulin resistance. This finding of insulin action in the brain could also be confirmed in human studies. The investigators intend to investigate whether central nervous insulin action affects insulin secretion in humans. For this purpose, nasal insulin and placebo are administered 15 minutes before a hyperglycemic hyperinsulinemic clamps, which stimulate insulin secretion. Insulin sensitivity of the brain is measured by a an established protocol with functional magnetic resonance imaging before and after nasal insulin administration.

Timeline

Start
2016-08
Primary completion
2018-02
Completion
2018-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 160 iu Intranasal